Cellectis S.A.
CMVLF
$4.50
-$0.54-10.71%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 158.90% | 332.15% | 825.97% | 5,397.35% | 76.24% |
| Total Other Revenue | 4.49% | 8.05% | 1.80% | -8.61% | -13.20% |
| Total Revenue | 129.04% | 223.06% | 351.22% | 435.32% | 46.95% |
| Cost of Revenue | -- | -- | -- | -- | 6.66% |
| Gross Profit | 133.82% | 235.66% | 380.41% | 481.97% | 48.12% |
| SG&A Expenses | 5.82% | 17.74% | 10.21% | 13.52% | 36.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -374.48% | -18,540.00% | -910.46% | -383.95% | 83.05% |
| Total Operating Expenses | -4.42% | 1.08% | 1.12% | 3.11% | 16.89% |
| Operating Income | 66.13% | 48.53% | 43.94% | 38.16% | -6.80% |
| Income Before Tax | 59.01% | 26.13% | 27.60% | 68.44% | 15.35% |
| Income Tax Expenses | 201.18% | 232.65% | 142.59% | -100.00% | -212.64% |
| Earnings from Continuing Operations | 58.15% | 25.23% | 27.38% | 68.54% | 16.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -100.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -100.00% |
| Net Income | 58.15% | 25.23% | 7.36% | 63.62% | 1.86% |
| EBIT | 66.13% | 48.53% | 43.94% | 38.16% | -6.80% |
| EBITDA | 79.36% | 57.31% | 51.18% | 44.05% | -7.85% |
| EPS Basic | 66.81% | 48.81% | 41.86% | 78.72% | 36.80% |
| Normalized Basic EPS | 63.03% | 41.48% | 43.36% | 78.23% | 46.26% |
| EPS Diluted | 72.45% | 57.08% | 51.77% | 65.52% | 23.46% |
| Normalized Diluted EPS | 63.95% | 42.83% | 44.54% | 76.80% | 44.87% |
| Average Basic Shares Outstanding | 22.02% | 41.14% | 57.36% | 58.98% | 57.19% |
| Average Diluted Shares Outstanding | 11.76% | 27.08% | 39.75% | 72.71% | 72.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |